KH906: A New Treatment for Corneal Neovascularization
Author Information
Author(s): Li Tao, Hu Andina, Li Shiqing, Luo Yan, Huang Juan, Yu Honghua, Ma Wei, Pan Jianying, Zhong Qi, Yang Jin, Wu Jianming, Tang Shibo
Primary Institution: Zhongshan Ophthalmic Center, Sun Yat-sen University
Hypothesis
The study investigates the effect of topical administration of KH906 on corneal neovascularization.
Conclusion
Topical administration of KH906 significantly inhibited corneal neovascularization in rabbits.
Supporting Evidence
- KH906-treated groups showed significantly reduced corneal neovascularization compared to the PBS control group.
- VEGF levels in the cornea decreased significantly in all KH906-treated groups.
- Corneal fluorescein staining indicated no adverse effects on corneal healing from KH906.
Takeaway
KH906 is a new eye drop that helps stop the growth of unwanted blood vessels in the eye, which can make it hard to see.
Methodology
Forty-eight rabbits were treated with different concentrations of KH906 after inducing corneal neovascularization through chemical cauterization.
Limitations
The study was conducted on rabbits, and further research is needed to confirm results in humans.
Participant Demographics
Forty-eight New Zealand white rabbits weighing between 2.2 kg and 2.5 kg.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website